 |
|
Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
E Sun Paik, Yoo-Young Lee, Eun-Jung Lee, Chel Hun Choi, Tae-Joong Kim, Jeong-Won Lee, Duk-Soo Bae, Byoung-Gie Kim
Obstet Gynecol Sci. 2015;58(2):124-134. Published online 2015 Mar 16 DOI: https://doi.org/10.5468/ogs.2015.58.2.124
|
|
Citations to this article as recorded by
 A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
Marie Métairie, Louise Benoit, Meriem Koual, Enrica Bentivegna, Henri Wohrer, Pierre-Adrien Bolze, Yohan Kerbage, Emilie Raimond, Cherif Akladios, Xavier Carcopino, Geoffroy Canlorbe, Jennifer Uzan, Vincent Lavoué, Camille Mimoun, Cyrille Huchon, Martin K
Cancers.2023; 15(3): 706. CrossRef Effect of Different Metastasis Pathways on Prognosis of Stage III High-Grade Serous Ovarian Cancer
梦瑶 夏
Advances in Clinical Medicine.2023; 13(03): 3298. CrossRef A retrospective analysis for investigating the relationship between FIGO stage IVA/IVB and cytoreductive surgery with prognosis in epithelial ovarian cancer
Hong Liu, Min Luo, Chunrong Peng, Jianmei Huang, Dengfeng Wang, Jianming Huang, Guonan Zhang
Frontiers in Oncology.2023;[Epub] CrossRef Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study
Mengdi Fu, Chengjuan Jin, Shuai Feng, Zongyang Jia, Lekai Nie, Yang Zhang, Jin Peng, Xia Wang, Hualei Bu, Beihua Kong
Frontiers in Oncology.2022;[Epub] CrossRef Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction
Mackenzie Cummings, Olivia Nicolais, Mark Shahin
Diagnostics.2022; 12(4): 988. CrossRef Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer
Kexin Wang, Hui He, Xue Feng, Fu Wang
Journal of Immunology Research.2022; 2022: 1. CrossRef WITHDRAWN: Fallopian tube cancer with inguinal lymph node metastasis as the first symptom: A case study and review of the literature
Qing Su, Ya Li, Jing Na, Shichao Han
International Journal of Surgery Case Reports.2022; : 107541. CrossRef High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation
Lin Xiu, Yuxi Zhao, Ning Li, Jia Zeng, Jing Liu, Yongliang Fu, Qiao Gao, Lingying Wu
Frontiers in Oncology.2022;[Epub] CrossRef Image-Guided Percutaneous Thermal Ablation of Oligometastatic Ovarian and Non-Ovarian Gynecologic Tumors
Frank Yuan, Sindy H. Wei, Gottfried E. Konecny, Sanaz Memarzadeh, Robert D. Suh, James Sayre, David S. Lu, Steven S. Raman
Journal of Vascular and Interventional Radiology.2021; 32(5): 729. CrossRef Serum Free Amino Acid Profiling in Differential Diagnosis of Ovarian Tumors—A Comparative Study with Review of the Literature
Agnieszka Horala, Szymon Plewa, Pawel Derezinski, Agnieszka Klupczynska, Jan Matysiak, Ewa Nowak-Markwitz, Zenon J. Kokot
International Journal of Environmental Research and Public Health.2021; 18(4): 2167. CrossRef Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases
Masafumi Yasunaga, Hideaki Yahata, Kaoru Okugawa, Emiko Hori, Keisuke Kodama, Hiroshi Yagi, Tatsuhiro Ohgami, Ichiro Onoyama, Kazuo Asanoma, Kiyoko Kato
International Journal of Clinical Oncology.2021; 26(7): 1330. CrossRef Free Amino Acid Alterations in Patients with Gynecological and Breast Cancer: A Review
Dagmara Pietkiewicz, Agnieszka Klupczynska-Gabryszak, Szymon Plewa, Magdalena Misiura, Agnieszka Horala, Wojciech Miltyk, Ewa Nowak-Markwitz, Zenon J. Kokot, Jan Matysiak
Pharmaceuticals.2021; 14(8): 731. CrossRef A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and cl
Wataru Yamagami, Satoru Nagase, Fumiaki Takahashi, Kazuhiko Ino, Toru Hachisuga, Mikio Mikami, Takayuki Enomoto, Hidetaka Katabuchi, Daisuke Aoki
Journal of Gynecologic Oncology.2020;[Epub] CrossRef Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution
Min-Hyun Baek, Jeong-Yeol Park, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim
Journal of Gynecologic Oncology.2020;[Epub] CrossRef Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
E Sun Paik, Jeong-Won Lee, Jeong-Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae, Sung Wook Seo
Journal of Gynecologic Oncology.2019;[Epub] CrossRef Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
Maite Timmermans, G S Sonke, K K Van de Vijver, P B Ottevanger, H W Nijman, M A van der Aa, R F P M Kruitwagen
International Journal of Gynecologic Cancer.2019; 29(2): 392. CrossRef Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer
Antonio González Martín, Amit M. Oza, Andrew C. Embleton, Jacobus Pfisterer, Jonathan A. Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Monique A. Bertrand, Philip Beale, Andrés Cervantes, Emma Kent, Richard S. Kaplan, Mahesh K.B. Parmar, Nana Scotto
Gynecologic Oncology.2019; 152(1): 53. CrossRef Wide spectrum targeted metabolomics identifies potential ovarian cancer biomarkers
Szymon Plewa, Agnieszka Horała, Paweł Dereziński, Ewa Nowak-Markwitz, Jan Matysiak, Zenon J. Kokot
Life Sciences.2019; 222: 235. CrossRef Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
Koji Matsuo, Hiroko Machida, Wataru Yamagami, Yasuhiko Ebina, Yoichi Kobayashi, Tsutomu Tabata, Masanori Kaneuchi, Satoru Nagase, Takayuki Enomoto, Mikio Mikami
Obstetrics & Gynecology.2019; 134(5): 1017. CrossRef Overexpression of miR‑148a inhibits viability and invasion of ovarian cancer OVCAR3 cells by targeting FOXO3
Dandan Zhu, Donglan Yuan, Runfa Guo, Lixin Zhang, Ting Guo, Yinling Zhao, Jia Wang, Xinping Chen, Hua Qian, Hongshan Ge
Oncology Letters.2019;[Epub] CrossRef Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
Elisabet Hjerpe, Christian Staf, Pernilla Dahm-Kähler, Karin Stålberg, Maria Bjurberg, Erik Holmberg, Christer Borgfeldt, Bengt Tholander, Kristina Hellman, Preben Kjølhede, Thomas Högberg, Per Rosenberg, Elisabeth Åvall-Lundqvist
Acta Oncologica.2018; 57(3): 331. CrossRef Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
Kira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen, Ib Jarle Christensen, Guy Wayne Novotny, Estrid Høgdall, Aamir Ahmad
PLOS ONE.2018; 13(11): e0207319. CrossRef The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy
Parvin Tajik, Roelien van de Vrie, Mohammad H. Zafarmand, Corneel Coens, Marrije R. Buist, Ignace Vergote, Patrick M.M. Bossuyt, Gemma G. Kenter
International Journal of Gynecologic Cancer.2018; 28(3): 453. CrossRef The role of neoadjuvant chemotherapy in ovarian cancer
Antoine Elies, Sophie Rivière, Nicolas Pouget, Véronique Becette, Coraline Dubot, Anne Donnadieu, Roman Rouzier, Claire Bonneau
Expert Review of Anticancer Therapy.2018; 18(6): 555. CrossRef Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial
Li Li, Qingqing Zhuang, Zeyi Cao, Rutie Yin, Yaping Zhu, Lirong Zhu, Xing Xie, Youzhong Zhang, Li Li, Qiang Wu, Jianhua Zheng, Qi Zhou, Xiaoping Li, Lingying Wu, Youji Feng, Changyu Wang
Oncology Letters.2018;[Epub] CrossRef Diaphragmatic smears are not of additional benefit in the detection of peritoneal spread in gynecological cancers
Celine Montavon, Uzma Mirza, Andre Fedier, Andreas Schoetzau, Rosanna Zanetti D�llenbach, Viola Heinzelmann‑Schwarz
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer
E Sun Paik, Minhee Shim, Hyun Jin Choi, Yoo-Young Lee, Tae-Joong Kim, Chel Hun Choi, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae
Cancer Biomarkers.2017; 17(4): 419. CrossRef The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis
Lili Zhao, Jun Li, Manli Liu, Hongrun Zhou, Hong Zou, Yutao Wei, Kunming Sun, Ganxiong Li, Shugang Li, Lijuan Pang
Future Oncology.2017; 13(28): 2555. CrossRef The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy
Kyung Jin Eoh, Jung Won Yoon, Inok Lee, Jung‐Yun Lee, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Eun Ji Nam
Journal of Surgical Oncology.2017; 116(3): 329. CrossRef Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy
Monika Englert-Golon, Bartosz Burchardt, Bartlomiej Budny, Szymon Dębicki, Blanka Majchrzycka, Elzbieta Wrotkowska, Piotr Jasiński, Katarzyna Ziemnicka, Radosław Słopień, Marek Ruchała, Stefan Sajdak
Oncology Letters.2017; 14(3): 3401. CrossRef A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
Kyung Jin Eoh, Jung Won Yoon, Jung-Yun Lee, Eun Ji Nam, Sunghoon Kim, Sang Wun Kim, Young Tae Kim
BMC Cancer.2017;[Epub] CrossRef Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?
Dimitrios Nasioudis, Eloise Chapman-Davis, Melissa K. Frey, Thomas A. Caputo, Steven S. Witkin, Kevin Holcomb
Gynecologic Oncology.2017; 147(1): 81. CrossRef Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
Kyung Jin Eoh, Jung-Yun Lee, Jung Won Yoon, Eun Ji Nam, Sunghoon Kim, Sang-Wun Kim, Young Tae Kim
Oncotarget.2017; 8(23): 37807. CrossRef Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type
Tayfun Toptas, Elif Pestereli, Onur Erol, Selen Bozkurt, Gulgun Erdogan, Tayup Simsek
International Journal of Gynecologic Cancer.2016; 26(6): 1012. CrossRef Abdominopelvic washings in gynecologic pathology: A comprehensive review
Jefree J. Schulte, Ricardo R. Lastra
Diagnostic Cytopathology.2016; 44(12): 1039. CrossRef FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited
Beyhan Ataseven, Luis M. Chiva, Philipp Harter, Antonio Gonzalez-Martin, Andreas du Bois
Gynecologic Oncology.2016; 142(3): 597. CrossRef Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virus
Marek Malecki, Emily Putzer, Caroline Quach, Chaitanya Dodivenaka, Xenia Tombokan
Clinical and Translational Medicine.2016;[Epub] CrossRef Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial Ovarian Carcinoma
Ga Won Yim, Kyung Jin Eoh, Sang Wun Kim, Eun Ji Nam, Young Tae Kim
Nutrition and Cancer.2016; 68(5): 772. CrossRef Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Mikkel Rosendahl, Claus Kim Høgdall, Berit Jul Mosgaard
International Journal of Gynecologic Cancer.2016; 26(4): 680. CrossRef The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
Beyhan Ataseven, Philipp Harter, Christoph Grimm, Florian Heitz, Sebastian Heikaus, Alexander Traut, Annett Kahl, Christian Kurzeder, Sonia Prader, Andreas du Bois
Gynecologic Oncology.2016; 142(2): 243. CrossRef
|